Crystal Growth & Design · 2011 · 133 citations · 19 references
PharmacyChemistryNutritional SciencesDissolution TestingPhysical ChemistrySolid-state ChemistryCrystal ChemistryCrystallization ProcessesDrug SolubilityPharmaceutical StabilitySolubility EnhancementSolubility OptimizationAqueous Solubility ImprovementCo-crystal FormationCocrystal FormationKinetic SolubilityPharmaceutical CocrystallizationSingle-crystal X-ray DiffractionSolubilitySolubility Determination
Pterostilbene is a nutraceutical compound being investigated for its ability to form cocrystals with pharmaceutically acceptable coformers to improve its poor aqueous solubility. Cocrystals of a 2:1 and 1:1 stoichiometric molar ratio of pterostilbene with piperazine or glutaric acid were synthesized on a multigram scale and fully characterized including single-crystal X-ray diffraction. Furthermore, both cocrystals were evaluated for physical stability with respect to humidity and temperature as well as kinetic solubility. Each cocrystal displayed remarkable stability, showing no evidence of dissociation across a range of durations, temperatures, and relative humidities. The aqueous concentration of pterostilbene measured over five hours from dissolution of the pterostilbene-piperazine cocrystal was six times higher than the solubility of the single-component pterostilbene. Although X-ray powder diffraction results indicate partial transformation of the pterostilbene-piperazine cocrystal to pterostilbene after 5 h, this increase in concentration was sustained throughout the dissolution experiment. Within 5 min of slurrying the pterostilbene-glutaric acid cocrystal in water, precipitation of pterostilbene was observed; thus no dissolution data under these conditions were obtained.
19
Solubility Advantage of Pharmaceutical Cocrystals
David Good, Naír Rodríguez‐Hornedo · Crystal Growth & Design · 2009 · 832 citations
S.L. Childs, Leonard J. Chyall, J.T. Dunlap et al. · Journal of the American Chemical Society · 2004 · 630 citations · Full text